← back to search

Daniel D. Buchanan

Morehouse College · US
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Genetic factors in colorectal cancer, Colorectal Cancer Screening and Detection, Colorectal Cancer Treatments and Studies, and Cancer Genomics and Diagnostics.
h-index
78
citations
23,254
works
886
NIH funding
primary concept
email

Recent publications

TGF-β Pathway–Based Polygenic Risk Score Modifies the Association between Red Meat Intake and Colorectal Cancer Risk: Application of a Novel Pathway-Based PRS Method
Cancer Epidemiology Biomarkers & Prevention 2026cited by 1position: middledoi
Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization Study
Cancer Epidemiology Biomarkers & Prevention 2025cited by 2position: middledoi
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis
JNCI Journal of the National Cancer Institute 2025cited by 2position: middledoi
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
EBioMedicine 2025cited by 2position: middledoi
Physical activity and molecular subtypes of colorectal cancer: a pooled observational analysis and Mendelian randomization study
JNCI Cancer Spectrum 2025cited by 1position: middledoi
Waist Circumference, a Body Shape Index, and Molecular Subtypes of Colorectal Cancer: A Pooled Analysis of Four Cohort Studies
Cancer Epidemiology Biomarkers & Prevention 2025cited by 1position: middledoi
Genetic risk factors modulate the association between physical activity and colorectal cancer
Research Square 2025cited by 1position: middledoi
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer
Annals of Oncology 2024cited by 67position: middledoi
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
EBioMedicine 2024cited by 44position: middledoi
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes
Nature Communications 2024cited by 18position: middledoi
Genome-wide interaction study of dietary intake of fibre, fruits, and vegetables with risk of colorectal cancer
EBioMedicine 2024cited by 12position: middledoi
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
British Journal of Cancer 2024cited by 10position: middledoi
Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses
EBioMedicine 2024cited by 9position: middledoi
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Science Advances 2024cited by 6position: middledoi
Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature
Cancer Epidemiology Biomarkers & Prevention 2024cited by 3position: middledoi
Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing
American Journal of Clinical Nutrition 2024cited by 3position: middledoi
Genetic Variation and Regulation of MICA Alters Natural Killer Cell-Mediated Immunosurveillance in Early-Onset Colorectal Cancer
medRxiv 2024cited by 0position: middledoi
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
EClinicalMedicine 2023cited by 103position: middledoi
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer
Gastroenterology 2023cited by 90position: middledoi
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study
International Journal of Cancer 2023cited by 60position: middledoi
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases
Journal of Gastroenterology 2023cited by 28position: middledoi
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
Nature Communications 2023cited by 27position: middledoi
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival
medRxiv 2023cited by 22position: lastdoi
Genome-Wide Gene–Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2023cited by 15position: middledoi
A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Cancer Research 2023cited by 14position: middledoi
Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation
JNCI Journal of the National Cancer Institute 2023cited by 12position: middledoi
Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
Gastroenterology 2023cited by 6position: middledoi
Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Nature Genetics 2023cited by 4position: middledoi
Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci
Cancer Epidemiology Biomarkers & Prevention 2023cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark A. Jenkins · Georgia Southern University19 papers (2012–2023)Polly A. Newcomb · University of Washington18 papers (2012–2022)John L. Hopper · National Institute on Deafness and Other Communication Disorders12 papers (2012–2023)Steven Gallinger · Ontario Institute for Cancer Research10 papers (2012–2021)Graham G. Giles · Monash Institute of Medical Research10 papers (2012–2021)Aung Ko Win · The Royal Melbourne Hospital9 papers (2012–2023)Loı̈c Le Marchand · The London College9 papers (2012–2023)Ulrike Peters · Fred Hutch Cancer Center9 papers (2019–2023)Noralane M. Lindor · Mayo Clinic in Florida8 papers (2012–2020)Michael Hoffmeister · Festo (Germany)7 papers (2019–2023)Mark Clendenning · St Michael's Hospital7 papers (2012–2021)Christophe Rosty · The University of Queensland7 papers (2012–2019)Peter T. Campbell · Montefiore Einstein Comprehensive Cancer Center7 papers (2018–2022)Marc J. Gunter · World Health Organization - Lyon Office6 papers (2020–2025)Hermann Brenner · Stanford University6 papers (2019–2025)Jane C. Figueiredo · University of Southern California6 papers (2018–2023)Tabitha A. Harrison · University of Washington6 papers (2019–2023)Roger L. Milne · Monash Institute of Medical Research6 papers (2017–2022)Robert W. Haile · Moffitt Cancer Center6 papers (2012–2020)Rish K. Pai · Sinai Health System6 papers (2021–2023)